These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing. Jiang H; Huang F; Chen X; Zhang L; Shen M; Pan B; Wang B; Guo W Mol Genet Genomic Med; 2023 Jul; 11(7):e2170. PubMed ID: 36978154 [TBL] [Abstract][Full Text] [Related]
4. Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis. Rebelatto TF; Falavigna M; Pozzari M; Spada F; Cella CA; Laffi A; Pellicori S; Fazio N Cancer Treat Rev; 2019 Nov; 80():101895. PubMed ID: 31542591 [TBL] [Abstract][Full Text] [Related]
5. Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation. Wattenberg MM; Asch D; Yu S; O'Dwyer PJ; Domchek SM; Nathanson KL; Rosen MA; Beatty GL; Siegelman ES; Reiss KA Br J Cancer; 2020 Feb; 122(3):333-339. PubMed ID: 31787751 [TBL] [Abstract][Full Text] [Related]
6. Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival. Kahn RM; Selenica P; Boerner T; Roche KL; Xiao Y; Sia TY; Maio A; Kemel Y; Sheehan M; Salo-Mullen E; Breen KE; Zhou Q; Iasonos A; Grisham RN; O'Cearbhaill RE; Chi DS; Berger MF; Kundra R; Schultz N; Ellenson LH; Stadler ZK; Offit K; Mandelker D; Aghajanian C; Zamarin D; Sabbatini P; Weigelt B; Liu YL Gynecol Oncol; 2024 Jan; 180():35-43. PubMed ID: 38041901 [TBL] [Abstract][Full Text] [Related]
7. Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma. Yadav S; Kasi PM; Bamlet WR; Ho TP; Polley EC; Hu C; Hart SN; Rabe KG; Boddicker NJ; Gnanaolivu RD; Lee KY; Lindstrom TH; Petersen GM; Couch FJ; McWilliams RR Clin Cancer Res; 2020 Dec; 26(24):6505-6512. PubMed ID: 33028596 [TBL] [Abstract][Full Text] [Related]
8. Retrospective Survival Analysis of Patients With Advanced Pancreatic Ductal Adenocarcinoma and Germline Reiss KA; Yu S; Judy R; Symecko H; Nathanson KL; Domchek SM JCO Precis Oncol; 2018 Nov; 2():1-9. PubMed ID: 35135099 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study. Cheng HF; Tsai YF; Liu CY; Hsu CY; Lien PJ; Lin YS; Chao TC; Lai JI; Feng CJ; Chen YJ; Chen BF; Chiu JH; Tseng LM; Huang CC Breast Cancer Res; 2023 Dec; 25(1):152. PubMed ID: 38098088 [TBL] [Abstract][Full Text] [Related]
10. Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma. Golan T; O'Kane GM; Denroche RE; Raitses-Gurevich M; Grant RC; Holter S; Wang Y; Zhang A; Jang GH; Stossel C; Atias D; Halperin S; Berger R; Glick Y; Park JP; Cuggia A; Williamson L; Wong HL; Schaeffer DF; Renouf DJ; Borgida A; Dodd A; Wilson JM; Fischer SE; Notta F; Knox JJ; Zogopoulos G; Gallinger S Gastroenterology; 2021 May; 160(6):2119-2132.e9. PubMed ID: 33524400 [TBL] [Abstract][Full Text] [Related]
11. BRCA1/BRCA2 Germline Mutation Carriers and Sporadic Pancreatic Ductal Adenocarcinoma. Blair AB; Groot VP; Gemenetzis G; Wei J; Cameron JL; Weiss MJ; Goggins M; Wolfgang CL; Yu J; He J J Am Coll Surg; 2018 Apr; 226(4):630-637.e1. PubMed ID: 29309945 [TBL] [Abstract][Full Text] [Related]
12. Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes. Olmos D; Lorente D; Alameda D; Cattrini C; Romero-Laorden N; Lozano R; Lopez-Casas PP; Jambrina A; Capone C; Vanden Broecke AM; Trevisan M; Van Sanden S; Jürgens A; Herrera-Imbroda B; Castro E Ann Oncol; 2024 May; 35(5):458-472. PubMed ID: 38417742 [TBL] [Abstract][Full Text] [Related]
13. Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter prospective study. Kubo T; Muramatsu J; Arihara Y; Murota A; Ishikawa K; Yoshida M; Nagashima H; Tamura F; Ikeda Y; Usami M; Ono M; Nakamura H; Watanabe D; Shibata T; Kasahara K; Sakurai A; Takada K Jpn J Clin Oncol; 2024 Jan; 54(1):47-53. PubMed ID: 37791389 [TBL] [Abstract][Full Text] [Related]
14. Platinum-based chemotherapy for pancreatic cancer: impact of mutations in the homologous recombination repair and Fanconi anemia genes. Emelyanova M; Pudova E; Khomich D; Krasnov G; Popova A; Abramov I; Mikhailovich V; Filipenko M; Menshikova S; Tjulandin S; Pokataev I Ther Adv Med Oncol; 2022; 14():17588359221083050. PubMed ID: 35309086 [TBL] [Abstract][Full Text] [Related]
15. Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in Reiss KA; Mick R; O'Hara MH; Teitelbaum U; Karasic TB; Schneider C; Cowden S; Southwell T; Romeo J; Izgur N; Hannan ZM; Tondon R; Nathanson K; Vonderheide RH; Wattenberg MM; Beatty G; Domchek SM J Clin Oncol; 2021 Aug; 39(22):2497-2505. PubMed ID: 33970687 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. Yin L; Wei J; Lu Z; Huang S; Gao H; Chen J; Guo F; Tu M; Xiao B; Xi C; Zhang K; Li Q; Wu J; Gao W; Jiang K; Yu J; Miao Y JAMA Netw Open; 2022 Feb; 5(2):e2148721. PubMed ID: 35171259 [TBL] [Abstract][Full Text] [Related]
18. Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing. Lee K; Yoo C; Kim KP; Park KJ; Chang HM; Kim TW; Lee JL; Lee W; Lee SS; Park DH; Song TJ; Seo DW; Lee SK; Kim MH; Shin SH; Hwang DW; Song KB; Lee JH; Kim SC; Ryoo BY Invest New Drugs; 2018 Feb; 36(1):163-169. PubMed ID: 28782087 [TBL] [Abstract][Full Text] [Related]
19. EUS-based Pancreatic Cancer Surveillance in Katona BW; Long JM; Ahmad NA; Attalla S; Bradbury AR; Carpenter EL; Clark DF; Constantino G; Das KK; Domchek SM; Dudzik C; Ebrahimzadeh J; Ginsberg GG; Heiman J; Kochman ML; Maxwell KN; McKenna DB; Powers J; Shah PD; Wangensteen KJ; Rustgi AK Cancer Prev Res (Phila); 2021 Nov; 14(11):1033-1040. PubMed ID: 34341011 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study. Joris S; Denys H; Collignon J; Rasschaert M; T'Kint de Roodenbeke D; Duhoux FP; Canon JL; Tejpar S; Mebis J; Decoster L; Aftimos P; De Grève J ESMO Open; 2023 Dec; 8(6):102041. PubMed ID: 37852034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]